Diary - News
All news PRAGMA awared 1st prize from UK charity Action on Hearing Loss
PRAGMA Therapeutics awarded first prize and £300,000 from UK charity action on hearing loss to develop new drugs to treat hearing loss.
PRAGMA Therapeutics SAS, a leading biopharmaceutical company in the field of stress and trauma-related disorders, announced today that it has received a Translational Research Initiative for Hearing (TRIH) award from the charity Action on Hearing Loss to develop novel small molecule drugs for the treatment of Sensorineural Hearing Lossin both civilian and military patient populations.
To this end, PRAGMA has established an international collaboration with world-renowned Professor Robert Frisina, Director of the Global Center for Hearing & Speech Research at the University of South Florida, and principal investigator to perform efficacy studies in translational animal models of hearing loss
